Brief: Richter, Allergan extend Cariprazine agreement to Latin America
June 21 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt
GDRB.BU:
RICHTER SAYS AMENDS EXISTING LICENSE AGREEMENT WITH ALLERGAN
PLC FOR CARIPRAZINE TO INCLUDE MAJOR MARKETS IN LATIN AMERICA
ALLERGAN WILL BE RESPONSIBLE FOR REGISTRATION OF PRODUCT IN
THE NEWLY LICENSED AREAS
Further company coverage: GDRB.BU
Source text: https://bet.hu/newkibdata/128248543/RCH190621ER01E.pdf
(Reporting by Krisztina Than)
((krisztina.than@thomsonreuters.com; +36 1 327 4745; Reuters
Messaging: krisztina.than.thomsonreuters.com@reuters.net))
Recent news on Gedeon Richter
See all newsBrief: Hungary's Richter says US FDA accepted for review its new drug application for Fylrevy
Brief: Hungary's Richter Upgrades 2026 Pharma Clean EBIT Guidance To Double-Digit Growth
development partnership in Tirzepatide
AI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection